Privia Health Group Q2 Earnings Call Highlights
Privia Health Group NASDAQ: PRVA reported second-quarter results marked by double-digit growth in implemented providers, attributed lives and practice collections, while adjusted EBITDA rose 29% from a year earlier. Management also raised its 2026 outlook for several financial measures following what Chief Executive Officer Parth Mehrotra described as strong first-half execution.
Privia Health Group, Inc. (PRVA) Q2 2026 Earnings Call Transcript
Privia Health Group, Inc. (PRVA) Q2 2026 Earnings Call Transcript
Compared to Estimates, Privia Health (PRVA) Q2 Earnings: A Look at Key Metrics
Although the revenue and EPS for Privia Health (PRVA) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Privia Health (PRVA) Misses Q2 Earnings Estimates
Privia Health (PRVA) came out with quarterly earnings of $0.07 per share, missing the Zacks Consensus Estimate of $0.08 per share. This compares to earnings of $0.02 per share a year ago.
Privia Health Group Q1 Earnings Call Highlights
Privia Health Group NASDAQ: PRVA reported a strong first quarter, with executives pointing to double-digit provider growth, a larger value-based care population and margin expansion as signs that the company's operating model continues to scale.
Privia Health Group, Inc. (PRVA) Q1 2026 Earnings Call Transcript
Privia Health Group, Inc. (PRVA) Q1 2026 Earnings Call Transcript
Privia Health (PRVA) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
Although the revenue and EPS for Privia Health (PRVA) give a sense of how its business performed in the quarter ended March 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Privia Health (PRVA) Misses Q1 Earnings Estimates
Privia Health (PRVA) came out with quarterly earnings of $0.02 per share, missing the Zacks Consensus Estimate of $0.08 per share. This compares to earnings of $0.03 per share a year ago.
Wall Street Analysts See a 43.44% Upside in Privia Health (PRVA): Can the Stock Really Move This High?
The average of price targets set by Wall Street analysts indicates a potential upside of 43.4% in Privia Health (PRVA). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Wall Street Analysts Think Privia Health (PRVA) Could Surge 25.45%: Read This Before Placing a Bet
The mean of analysts' price targets for Privia Health (PRVA) points to a 25.5% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Privia Health Group, Inc. (PRVA) Q4 2025 Earnings Call Transcript
Privia Health Group, Inc. (PRVA) Q4 2025 Earnings Call Transcript
Privia Health (PRVA) Reports Q4 Earnings: What Key Metrics Have to Say
Although the revenue and EPS for Privia Health (PRVA) give a sense of how its business performed in the quarter ended December 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
